Menopausal hormone therapy no longer has the highest-level warning label about the risk of breast cancer, opening a gray area on who would benefit most from treatment.
Articles on Breast cancer survival
Displaying all articles
Our research shows most women aren’t meeting lifestyle recommendations that can help prevent cancer recurrence.
A new breast cancer test predicts whether a patient will benefit from endocrine therapy, allowing patients and their doctors to make better treatment decisions.
Breast cancer, once a death sentence, now has a survival rate of more than 90 percent. This means that millions of women suffer effects of treatment. Recent research shows ways to overcome them.
Top contributors
-
Assistant Professor, exercise science and physiology, Roanoke College
-
Professor, Exercise Sciences, Florida State University
-
Research Trial Coordinator, The University of Queensland
-
Associate Professor, Auckland University of Technology
-
Professor
-
Faculty deputy dean, Queensland University of Technology; The University of Queensland
-
PhD Candidate, The University of Queensland
-
Clinical Assistant Professor; Director, Cancer Genetics & Breast Health, University of Michigan